Navigation Links
BioCrossroads Invests in Innovative Biotech Targeting Challenging Diseases
Date:12/23/2010

INDIANAPOLIS, Dec. 23, 2010 /PRNewswire/ -- BioCrossroads' Indiana Seed Fund has announced its eleventh investment, committing $250,000 to biotech start-up Aarden Pharmaceuticals.  Based in Indianapolis but drawing key parts of its veteran entrepreneurial team from San Diego, Aarden is developing novel technologies to attack difficult-to-treat diseases through focus on specific intracellular disease targets. The BioCrossroads investment will support the company to advance its lead program, a tuberculosis (TB) treatment, through the pre-clinical development stage. 

Aarden's scientific platform comes through the work of Dr. Zhong-Yin Zhang, Robert A. Harris Professor and Chairman of Biochemistry and Molecular Biology at Indiana University School of Medicine, and an internationally recognized expert in the field of protein tyrosine phosphatases (PTPs), a large family of signaling enzymes that regulate a wide array of essential cellular processes.  Dr. Zhang's work is based on novel chemistry that allows drugs to work more effectively in finding their targets.

"Aarden's research was born in Dr. Zhang's laboratory, which was funded through Lilly Endowment's historic Indiana Genomics Initiative (INGEN) grant to the Indiana University School of Medicine several years ago," said David Johnson, president and CEO of BioCrossroads.  "The goal of INGEN was to make Indiana a destination point for 21st century biotechnology discovery and, in so doing, bring more translational research to life for better human health.  Aarden's promising science, pre-eminent research and outstanding leadership team illustrate very well the full promise of the grant."

The second leading cause of death in the world, approximately 2 million people die from tuberculosis each year.   Current treatments are insufficient.  Often, existing antibiotics are not fully effective, particularly against multi-drug resistant TB under a regimen that
'/>"/>

SOURCE BioCrossroads
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioCrossroads Indiana Seed Fund Invests in Vaccine Biotech Company
2. BioCrossroads Invests in Indianapolis Biotech Company Developing Treatments for Alzheimers Disease
3. Orthopedics Entrepreneur Named BioCrossroads Watanabe Life Sciences Champion of the Year
4. Carilion Clinic Invests in Sight Saving Technology to Improve Patient Care: Carilion Clinic Teams Up with Retasure
5. Lockheed Martin Invests in Smart Grid Research and Development at Penn State University
6. Burrill & Company Invests in Taiwan Liposome Company
7. University of Lodz Invests in the Unique Cellaxess(R)HT System for Research on Multidrug Resistance Genes in Cancer
8. The Pittsburgh Life Sciences Greenhouse Invests $725K in Portfolio Companies
9. Syngenta Ventures Invests in U.S. Biotech Company Metabolon
10. BR Ventures Invests in Semprae Laboratories
11. Federal grant invests in nanostructured super materials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014 The patent provides ... diagnostic test results. It also enables true sample ... validation and reporting of high profile assays such ... a rapidly growing area of biotechnology that includes ... cancer, and companion diagnostics in personalized medicine. The ...
(Date:7/23/2014)... Russian Quantum Center at Skolkovo) and Mario Ziman ... Institute of Physics in Bratislava, Slovakia) have found ... passing through an amplifier and, conversely, when transmitting ... in an article published in the journal ... entangled particles are considered to be the basis ...
(Date:7/23/2014)... 2014 Last year, Formedix ... leading global provider of data management solutions for clinical ... leading-edge system for electronic data capture (EDC) and clinical ... and study execution tools added TrialMaster to its Transform ... version of Transform for TrialMaster, is being released this ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 DuPont Pioneer ... business as vice president of Agricultural Biotechnology (ABT), effective ... where he served most recently as president, chief executive ... and business leadership in the seed and crop protection ... Paul E. Schickler , president of DuPont Pioneer. ...
Breaking Biology Technology:New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3
... 31 Savient,Pharmaceuticals, Inc. (Nasdaq: SVNT ) today ... and Drug Administration (FDA) seeking approval to,market pegloticase in ... review. Savient,s filing includes data from both the six-month,placebo ... from the Open,Label Extension (OLE) study. The data set ...
... 31 /Xinhua-PRNewswire/ -- Sundia MediTech,Company, a Shanghai-based drug ... this year,s Deloitte Technology,Fast 50 China award, and ... 50 China Program was announced today in Shenzhen, ... 50 Program started in 1995 in San Jose. ...
... than a dozen employers in health care, employment continued to increase in ... like no one was searching for those new jobs. , ... Seattle, ... care field, with an average of 30,000 jobs created each month. Even ...
Cached Biology Technology:Savient Submits Biologics License Application (BLA) for pegloticase 2Savient Submits Biologics License Application (BLA) for pegloticase 3Savient Submits Biologics License Application (BLA) for pegloticase 4Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China 2The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 2The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 3
(Date:7/23/2014)... from cystic fibrosis patients, scientists at the UNC School ... shown that a new CF drug counteracts the intended ... finding, published today in the journal Science Translational ... unstable and loses its ability to function properly when ... offers several insights into how novel CF pharmacotherapies could ...
(Date:7/23/2014)... Canada has issued a high health risk warning for ... the region due to forest fires. In the ... drifting eastward along normal wind patterns. Fire is ... from fires is not quite so obvious and its ... type of fire (forest, brush, crop, structure, tires, waste ...
(Date:7/23/2014)... songbirds are disappearing, and though conservationists are examining several ... acid rain and light pollution, a key piece of ... go once they leave their breeding sites, and what ... To answer this question, a team of researchers out ... connectivity map produced for a songbird, using tracking from ...
Breaking Biology News(10 mins):UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 2UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 3UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 4York University researchers use bird 'backpacks' to put wood thrushes migration on the map 2
... the IST project OPTONANOGEN, a prototype of the system will ... that are responsible for between 2.5 and 5 per cent ... system, however, could be used to detect virtually any genetic ... in food or water pollution. , "There are a broad ...
... Employing a simple new technique to manipulate the sugars ... scientists has enhanced the antic-cancer properties of a digitalis, ... Reporting the work in the Aug. 8 edition of ... team led by University of Wisconsin-Madison professor of pharmaceutical ...
... new study reports for the first time that a less-virulent ... humans. The research appears in the October 1 issue ... Crossing the species barrier is an important step in the ... have focused on the ability of highly pathogenic strains, such ...
Cached Biology News:Nanotechnology to provide portable genetic risk detection 2UW-Madison scientists zero in on drugs' sweet spots 2UW-Madison scientists zero in on drugs' sweet spots 3European Commission funds EBI to do new research on synergies between bioinformatics and medical informatics 2
... provides complete components including positive and ... of DNA fragmentation in cultured cells ... BrdU in the procedure provides greater ... Results can be analyzed by fluorescence ...
... LAS-3000 imaging system combines new CCD ... interface, providing significantly improved system sensitivity ... The system is especially dedicated to ... system for Western blotting applications.,Fuiji's LAS-3000 ...
... The Fujifilm Life Science LAS-3000mini is ... dedicated to chemiluminescence applications, and the ... applications., Fuiji 's LAS-3000 provides significantly ... digitization. , Glowell calibration standards validate ...
... 50 assays. The TUNEL-based assay kit provides ... cells for convenient detection of DNA fragmentation ... assay offers an one-step labeling of apoptotic ... a hallmark of apoptosis in mammalian cells. ...
Biology Products: